Lumentum Holdings Inc.: Form 10-K for the period ended Jul 2, 2022
Filed with the SEC on Aug 24, 2022 and accepted by EDGAR at Aug 24, 2022, 20:45 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-07-02. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Gross profit | 12 months2021-07-04 to 2022-07-02 | $788.6m | us-gaap:GrossProfit |
| Research and development | 12 months2021-07-04 to 2022-07-02 | $220.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2021-07-04 to 2022-07-02 | $265.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2021-07-04 to 2022-07-02 | $303.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2021-07-04 to 2022-07-02 | $80.2m | us-gaap:InterestExpense |
| Income tax | 12 months2021-07-04 to 2022-07-02 | $36.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2021-07-04 to 2022-07-02 | $198.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2021-07-04 to 2022-07-02 | $2.68 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2021-07-04 to 2022-07-02 | $2.79 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2021-07-04 to 2022-07-02 | 74,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2021-07-04 to 2022-07-02 | $459.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2021-07-04 to 2022-07-02 | $91.2m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 12 months2021-07-04 to 2022-07-02 | $543.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2022-07-02 | $1.29bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-07-02 | $3.14bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-07-02 | $4.16bn | us-gaap:Assets |
| Current liabilities | At period end2022-07-02 | $716.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-07-02 | $2.29bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2022-07-02 | $1.88bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-22-023617. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.